Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANNA GADDY

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1619326980
CMS profile
5699694
Location
MILWAUKEE, WI

General Payments · PY2018–2024

$16,014.19

  • Reported across 17 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$15,864.36

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $14,302.00 2
Travel and Lodging $837.89 5
Food and Beverage $724.47 8

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $76.92 1
PY2022 $72.91 1
PY2024 $15,864.36 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182022 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $124.99 06/17/2024 Food and Beverage Undisputed 01/23/2026 1094026614 CMS
CALLIDITAS THERAPEUTICS US INC. $2,250.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1141521913 CMS
Mallinckrodt Hospital Products Inc. $131.38 06/13/2024 Food and Beverage Undisputed 01/23/2026 1145073612 CMS
Otsuka America Pharmaceutical, Inc. $53.45 08/25/2024 Food and Beverage Undisputed 01/23/2026 1118894982 CMS
Otsuka America Pharmaceutical, Inc. $430.45 08/25/2024 Travel and Lodging Undisputed 01/23/2026 1118894984 CMS
Otsuka America Pharmaceutical, Inc. $303.97 08/26/2024 Travel and Lodging Undisputed 01/23/2026 1118894986 CMS
Otsuka America Pharmaceutical, Inc. $38.99 08/26/2024 Travel and Lodging Undisputed 01/23/2026 1118894988 CMS
Otsuka America Pharmaceutical, Inc. $43.78 08/26/2024 Food and Beverage Undisputed 01/23/2026 1118894990 CMS
Otsuka America Pharmaceutical, Inc. $52.60 08/26/2024 Food and Beverage Undisputed 01/23/2026 1118894992 CMS
Otsuka America Pharmaceutical, Inc. $30.48 08/26/2024 Travel and Lodging Undisputed 01/23/2026 1118894994 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $12,052.00 10/03/2024 Consulting Fee Undisputed 01/23/2026 1118836695 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $34.00 10/08/2024 Travel and Lodging Undisputed 01/23/2026 1118836697 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $36.81 10/08/2024 Food and Beverage Undisputed 01/23/2026 1118836699 CMS
Travere Therapeutics, Inc. $161.63 10/23/2024 Food and Beverage Undisputed 01/23/2026 1149894596 CMS
Travere Therapeutics, Inc. $119.83 11/06/2024 Food and Beverage Undisputed 01/23/2026 1149894592 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2022, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2022 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.